Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

The company promoted by GSK Velu, who was an investor in diagnostic chain Metropolis Healthcare, will use the proceeds of this pre-initial public offering fundraising to bolster its merger and ...

Neuberg Diagnostics is in talks with a consortium of investors, including funds managed by 360One and foreign investor M&G ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

Shares of firms like Bajaj Housing Finance, Patanjali Foods, SpiceJet, Tata Power, HUL, ONGC, and others will be in focus on ...

The US FDA has issued a warning letter to Zydus Lifesciences citing significant manufacturing lapses at its Gujarat-based ...

The merger solves problems for both companies ... for $9.7 billion to get hold of the cholesterol drug inclisiran and GlaxoSmithKline’s $5.1 billion buy of cancer drugs firm Tesaro got ...

GSK has worked closely with government and industry ... Regulatory Affairs services of the company and as part of the merger team overseeing the integration of Glaxo Wellcome and SmithKline ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...